Middle East & Africa Bioproduction Market Forecast to 2030

Middle East & Africa Bioproduction Market Forecast to 2030

Middle East & Africa Bioproduction Market Forecast to 2030 – Regional Analysis – by Product (Biologics and Biosimilars, Vaccines, Cell and Gene Therapies, Nucleic Acid Therapeutics, and Others), Application (Rheumatoid Arthritis, Hematological Disorders, Cancer, Diabetes, Cardiovascular Diseases, and Others), Equipment (Upstream Equipment, Downstream Equipment, Bioreactors, and Consumables and Accessories), and End User (Biopharmaceutical Companies, Contract Manufacturing Organizations, and Others)

Send Enquiry
Item ID: BMIRE00030061 Category: Tag:

$2,840 – $4,440

Description

The Middle East & Africa bioproduction market was valued at US$ 283.68 million in 2022 and is expected to reach US$ 652.96 million by 2030; it is estimated to register a CAGR of 11.0% from 2022 to 2030.

Shift Toward Automated Cell Therapy Manufacturing Bolsters Middle East & Africa Bioproduction Market

Automation can deliver many benefits for cell therapy developers, including reduced risk of contamination, improved consistency, and reduced cost of production. Many companies have offered devices to enable automation, such as the Lonza Cocoon and the CliniMACS Prodigy system from Miltenyi are designed to enable the automation of most sequential unit operations for a CAR-T process within a single system. A rising number of cell therapies have shifted the production of cell therapy products from a small volume to a large volume worldwide. In addition, the evolution of cell therapy, from an academic and clinical setting to mass production and commercialization, is increasing the demand for automation in manufacturing. Increasing research activities in cell therapies have led to a rise in demand for advanced manufacturing solutions. In view of this, many players are offering products to meet the digital needs of academic researchers and large biotechnology companies. For instance, in May 2019, GE Healthcare launched the Chronicle web application to support the complete cell therapy workflow. Chronicle automation software is a good manufacturing practice (GMP)-compliant digital solution designed to optimize complex cell therapy process development and manufacturing.

Companies are also entering into strategic and technological developments for automation in cell therapy. For instance, in July 2020, Thermo Fisher Scientific Inc. and Lyell Immunopharma partnered to develop and manufacture processes to design effective cell therapies for cancer patients. Under this partnership, the companies aim to improve the fitness of T-cells and support the development of an integrated current good manufacturing practice (cGMP) compliant platform (system and software) along with reagents, consumables, and instruments. Thus, the increasing adoption of automation among cell therapy manufacturers is anticipated to drive the market.

Middle East & Africa Bioproduction Market Overview

The bioproduction market in the Middle East & Africa includes a country-level analysis of the UAE, Saudi Arabia, South Africa, and the Rest of Middle East & Africa. The bioproduction market growth can be attributed to changing government policies, increasing private-public partnerships, and improving healthcare infrastructure. Moreover, the increasing demand for advanced and effective cell therapies is facilitating the market growth.

According to the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), cardiovascular disease was the foremost cause of death in Saudi Arabia in 2020, accounting for 45.7% of all death cases. Further, there is a high prevalence of diabetes in Saudi Arabia due to unhealthy eating habits and sedentary lifestyles. According to IDF, the frequency rate of diabetes in Saudi Arabia ranged from 8% to 22% in 2021. The factors majorly contributing to diabetes are obesity, unhealthy lifestyle, and genetic susceptibility. According to a nationwide survey, Saudi Arabia had 5.5% of cardiovascular disease prevalence in 2022. Thus, the growing incidence rate of cardiovascular diseases and diabetes in Saudi Arabia is driving the growth of the bioproduction market.

Middle East & Africa Bioproduction Market Revenue and Forecast to 2030 (US$ Million)

Middle East & Africa Bioproduction Market Segmentation

The Middle East & Africa bioproduction market is categorized into product, application, equipment, end user, and country.

Based on product, the Middle East & Africa bioproduction market is segmented into biologics and biosimilars, vaccines, cell and gene therapies, nucleic acid therapeutics, and others. The biologics and biosimilars segment held the largest Middle East & Africa bioproduction market share in 2022.

In terms of application, the Middle East & Africa bioproduction market is segmented into rheumatoid arthritis, hematological disorders, cancer, diabetes, cardiovascular diseases, and others. The cancer segment held the largest Middle East & Africa bioproduction market share in 2022.

By equipment, the Middle East & Africa bioproduction market is divided into upstream equipment, downstream equipment, bioreactors, and consumables and accessories. The consumables and accessories segment held the largest Middle East & Africa bioproduction market share in 2022.

In terms of end user, the Middle East & Africa bioproduction market is categorized into biopharmaceutical companies, contract manufacturing organizations, and others. The biopharmaceutical companies segment held the largest Middle East & Africa bioproduction market share in 2022.

By country, the Middle East & Africa bioproduction market is segmented into Saudi Arabia, the UAE, South Africa, and the Rest of Middle East & Africa. Saudi Arabia dominated the Middle East & Africa bioproduction market share in 2022.

Lonza Group AG, Danaher Corp, Sartorius AG, Thermo Fisher Scientific Inc, Merck KGaA, F. Hoffmann-La Roche Ltd, and Bio-Rad Laboratories Inc. are some of the leading companies operating in the Middle East & Africa bioproduction market.

Summary Info

Industry:

Pricing options:

, ,

Geographical coverage:

,

Year of Publication:

At 11.0% CAGR, Middle East & Africa Bioproduction Market is Speculated to be Worth US$ 652.96 Million by 2030, says the Research Team

According to the Research Team’ research, the Middle East & Africa bioproduction market was valued at US$ 283.68 million in 2022 and is expected to reach US$ 652.96 million by 2030, registering a CAGR of 11.0% from 2022 to 2030. Rising adoption of regenerative medicines and increasing prevalence of chronic diseases are among the critical factors attributed to drive the Middle East & Africa bioproduction market growth.

Regenerative therapies help in the regeneration of cells, tissues, and organs to restore their functions. A number of regenerative medicine applications for human clinical trials are submitted to the Food and Drug Administration (FDA) each year. As per the Alliance for Regenerative Medicine, in 2019 (Q3), 1,052 clinical trials utilizing regenerative medicine were underway globally; 218 cellular therapy trials were underway (41 Phase I, 147 Phase II, 30 Phase III) in 2019. Rapid advancements are being made in regenerative medicines to provide effective solutions for chronic conditions. Cell therapy is one of the fastest-growing segments of the regenerative medicine domain. Novartis’ Kymriah was the first cell therapy solution offered to treat B-cell acute leukemia. Moreover, RepliCel, a regenerative medicine provider, has a wide range of regenerative medicine products in the pipeline, with three products-RCH-01, RCS-01, and RCT-01-in the development phase. Further, Sernova is engaged in the development of regenerative medicine technologies and has a huge pipeline of products for conditions such as diabetes, hemophilia A, and hyperthyroidism. Thus, the rising adoption of regenerative medicines is driving the bioproduction market.

On the contrary, high cost of cell therapy and biosimilar manufacturing hampers the growth of Middle East & Africa bioproduction market.

Based on product, the Middle East & Africa bioproduction market is segmented into biologics and biosimilars, vaccines, cell and gene therapies, nucleic acid therapeutics, and others. The biologics and biosimilars segment held 37.6% Middle East & Africa bioproduction market share in 2022, amassing US$ 106.57 million. It is projected to garner US$ 229.59 million by 2030 to register 10.1% CAGR during 2022-2030.

In terms of application, the Middle East & Africa bioproduction market is segmented into rheumatoid arthritis, hematological disorders, cancer, diabetes, cardiovascular diseases, and others. The cancer segment held 37.6% share of Middle East & Africa bioproduction market in 2022, amassing US$ 106.70 million. It is anticipated to garner US$ 255.56 million by 2030 to expand at 11.5% CAGR during 2022-2030.

By equipment, the Middle East & Africa bioproduction market is divided into upstream equipment, downstream equipment, bioreactors, and consumables and accessories. The consumables and accessories segment held 39.3% share of Middle East & Africa bioproduction market in 2022, amassing US$ 111.62 million. It is projected to garner US$ 271.66 million by 2030 to expand at 11.8% CAGR from 2022 to 2030.

In terms of end user, the Middle East & Africa bioproduction market is categorized into biopharmaceutical companies, contract manufacturing organizations, and others. The biopharmaceutical companies segment held 52.9% share of Middle East & Africa bioproduction market in 2022, amassing US$ 150.08 million. It is projected to garner US$ 341.90 million by 2030 to expand at 10.8% CAGR from 2022 to 2030.

Based on country, the Middle East & Africa bioproduction market is categorized into Saudi Arabia, the UAE, South Africa, and the Rest of Middle East & Africa. Our regional analysis states that Saudi Arabia captured 39.9% share of Middle East & Africa bioproduction market in 2022. It was assessed at US$ 113.13 million in 2022 and is likely to hit US$ 268.76 million by 2030, registering a CAGR of 11.4% during 2022-2030.

Key players operating in the Middle East & Africa bioproduction market are Lonza Group AG, Danaher Corp, Sartorius AG, Thermo Fisher Scientific Inc, Merck KGaA, F. Hoffmann-La Roche Ltd, and Bio-Rad Laboratories Inc., among others.

o Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Middle East & Africa bioproduction market.
o Highlights key business priorities in order to assist companies to realign their business strategies.
o The key findings and recommendations highlight crucial progressive industry trends in the Middle East & Africa bioproduction market, thereby allowing players across the value chain to develop effective long-term strategies.
o Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
o Scrutinize in-depth Middle East & Africa market trends and outlook coupled with the factors driving the Middle East & Africa bioproduction market, as well as those hindering it.
o Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.

TABLE OF CONTENTS

1. Introduction
1.1 the Research Team Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Middle East & Africa Bioproduction Market – Key Industry Dynamics
4.1 Market Drivers
4.1.1 Rising Adoption of Regenerative Medicines
4.1.2 Increasing Prevalence of Chronic Diseases
4.2 Market Restraints
4.2.1 High Cost of Cell Therapy and Biosimilar Manufacturing
4.3 Market Opportunities
4.3.1 Patent Expiry of Blockbuster Biologics
4.4 Future Trends
4.4.1 Shift Toward Automated Cell Therapy Manufacturing
4.5 Impact Analysis
5. Bioproduction Market – Middle East & Africa Market Analysis
5.1 Middle East & Africa Bioproduction Market Revenue (US$ Mn), 2020 – 2030
6. Middle East & Africa Bioproduction Market – Revenue and Forecast to 2030 – by Product
6.1 Overview
6.2 Middle East & Africa Bioproduction Market Revenue Share, by Product 2022 & 2030 (%)
6.3 Biologics and Biosimilars
6.3.1 Overview
6.3.2 Biologics and Biosimilars: Middle East & Africa Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
6.4 Vaccines
6.4.1 Overview
6.4.2 Vaccines: Middle East & Africa Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
6.5 Cell and Gene Therapies
6.5.1 Overview
6.5.2 Cell and Gene Therapies: Middle East & Africa Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
6.6 Nucleic Acid Therapeutics
6.6.1 Overview
6.6.2 Nucleic Acid Therapeutics: Middle East & Africa Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
6.7 Others
6.7.1 Overview
6.7.2 Others: Middle East & Africa Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
7. Middle East & Africa Bioproduction Market – Revenue and Forecast to 2030 – by Application
7.1 Overview
7.2 Middle East & Africa Bioproduction Market Revenue Share, by Application 2022 & 2030 (%)
7.3 Cancer
7.3.1 Overview
7.3.2 Cancer: Middle East & Africa Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
7.4 Cardiovascular Diseases
7.4.1 Overview
7.4.2 Cardiovascular Diseases: Middle East & Africa Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
7.5 Rheumatoid Arthritis
7.5.1 Overview
7.5.2 Rheumatoid Arthritis: Middle East & Africa Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
7.6 Hematological Disorders
7.6.1 Overview
7.6.2 Hematological Disorders: Middle East & Africa Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
7.7 Diabetes
7.7.1 Overview
7.7.2 Diabetes: Middle East & Africa Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
7.8 Others
7.8.1 Overview
7.8.2 Others: Middle East & Africa Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
8. Middle East & Africa Bioproduction Market – Revenue and Forecast to 2030 – by Equipment
8.1 Overview
8.2 Middle East & Africa Bioproduction Market Revenue Share, by Equipment 2022 & 2030 (%)
8.3 Consumables and Accessories
8.3.1 Overview
8.3.2 Consumables and Accessories: Middle East & Africa Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
8.4 Downstream Equipment
8.4.1 Overview
8.4.2 Downstream Equipment: Middle East & Africa Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
8.5 Bioreactors
8.5.1 Overview
8.5.2 Bioreactors: Middle East & Africa Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
8.5.2.1 Middle East & Africa: Bioproduction Market, For Bioreactors by Equipment, 2020-2030 (US$ Million)
8.6 Upstream Equipment
8.6.1 Overview
8.6.2 Upstream Equipment: Middle East & Africa Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
9. Middle East & Africa Bioproduction Market – Revenue and Forecast to 2030 – by End User
9.1 Overview
9.2 Middle East & Africa Bioproduction Market Revenue Share, by End User 2022 & 2030 (%)
9.3 Biopharmaceutical Companies
9.3.1 Overview
9.3.2 Biopharmaceutical Companies: Middle East & Africa Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
9.4 Contract Manufacturing Organizations
9.4.1 Overview
9.4.2 Contract Manufacturing Organizations: Middle East & Africa Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
9.5 Others
9.5.1 Overview
9.5.2 Others: Middle East & Africa Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
10. Middle East & Africa Bioproduction Market – Revenue and Forecast to 2030 – Country Analysis
10.1 Middle East & Africa Bioproduction Market
10.1.1.1 Saudi Arabia: Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
10.1.1.1.1 Saudi Arabia: Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
10.1.1.1.2 Saudi Arabia: Bioproduction Market, by Product, 2020-2030 (US$ Million)
10.1.1.1.3 Saudi Arabia: Bioproduction Market, by Application, 2020-2030 (US$ Million)
10.1.1.1.4 Saudi Arabia: Bioproduction Market, by Equipment, 2020-2030 (US$ Million)
10.1.1.1.4.1 Saudi Arabia: Bioproduction Market, For Bioreactors by Equipment, 2020-2030 (US$ Million)
10.1.1.1.5 Saudi Arabia: Bioproduction Market, by End User, 2020-2030 (US$ Million)
10.1.1.2 South Africa: Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
10.1.1.2.1 Overview
10.1.1.2.2 South Africa: Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
10.1.1.2.3 South Africa: Bioproduction Market, by Product, 2020-2030 (US$ Million)
10.1.1.2.4 South Africa: Bioproduction Market, by Application, 2020-2030 (US$ Million)
10.1.1.2.5 South Africa: Bioproduction Market, by Equipment, 2020-2030 (US$ Million)
10.1.1.2.5.1 South Africa: Bioproduction Market, For Bioreactors by Equipment, 2020-2030 (US$ Million)
10.1.1.2.6 South Africa: Bioproduction Market, by End User, 2020-2030 (US$ Million)
10.1.1.3 UAE: Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
10.1.1.3.1 Overview
10.1.1.3.2 UAE: Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
10.1.1.3.3 UAE: Bioproduction Market, by Product, 2020-2030 (US$ Million)
10.1.1.3.4 UAE: Bioproduction Market, by Application, 2020-2030 (US$ Million)
10.1.1.3.5 UAE: Bioproduction Market, by Equipment, 2020-2030 (US$ Million)
10.1.1.3.5.1 UAE: Bioproduction Market, For Bioreactors by Equipment, 2020-2030 (US$ Million)
10.1.1.3.6 UAE: Bioproduction Market, by End User, 2020-2030 (US$ Million)
10.1.1.4 Rest of Middle East & Africa: Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
10.1.1.4.1 Overview
10.1.1.4.2 Rest of Middle East & Africa: Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
10.1.1.4.3 Rest of Middle East & Africa: Bioproduction Market, by Product, 2020-2030 (US$ Million)
10.1.1.4.4 Rest of Middle East & Africa: Bioproduction Market, by Application, 2020-2030 (US$ Million)
10.1.1.4.5 Rest of Middle East & Africa: Bioproduction Market, by Equipment, 2020-2030 (US$ Million)
10.1.1.4.5.1 Rest of Middle East & Africa: Bioproduction Market, For Bioreactors by Equipment, 2020-2030 (US$ Million)
10.1.1.4.6 Rest of Middle East & Africa: Bioproduction Market, by End User, 2020-2030 (US$ Million)
11. Bioproduction Market-Industry Landscape
11.1 Overview
11.2 Growth Strategies in the Bioproduction Market
11.3 Inorganic Growth Strategies
11.3.1 Overview
11.4 Organic Growth Strategies
11.4.1 Overview
12. Company Profiles
12.1. Lonza Group AG
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Danaher Corp
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Sartorius AG
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Thermo Fisher Scientific Inc
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Merck KGaA
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 F. Hoffmann-La Roche Ltd
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Bio-Rad Laboratories Inc
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
13. Appendix
13.1 About Us
13.2 Glossary of Terms

LIST OF TABLES

Table 1. Middle East & Africa Bioproduction Market Segmentation
Table 2. Middle East & Africa Bioproduction Market, For Bioreactors by Equipment – Revenue and Forecast to 2030 (US$ Million)
Table 3. Saudi Arabia Bioproduction Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 4. Saudi Arabia Bioproduction Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 5. Saudi Arabia Bioproduction Market, by Equipment – Revenue and Forecast to 2030 (US$ Million)
Table 6. Saudi Arabia Bioproduction Market, For Bioreactors by Equipment by Application – Revenue and Forecast to 2030 (US$ Million)
Table 7. Saudi Arabia Bioproduction Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 8. South Africa Bioproduction Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 9. South Africa Bioproduction Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 10. South Africa Bioproduction Market, by Equipment – Revenue and Forecast to 2030 (US$ Million)
Table 11. South Africa Bioproduction Market, For Bioreactors by Equipment- Revenue and Forecast to 2030 (US$ Million)
Table 12. South Africa Bioproduction Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 13. UAE Bioproduction Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 14. UAE Bioproduction Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 15. UAE Bioproduction Market, by Equipment – Revenue and Forecast to 2030 (US$ Million)
Table 16. UAE Bioproduction Market, For Bioreactors by Equipment- Revenue and Forecast to 2030 (US$ Million)
Table 17. UAE Bioproduction Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 18. Rest of Middle East & Africa Bioproduction Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 19. Rest of Middle East & Africa Bioproduction Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 20. Rest of Middle East & Africa Bioproduction Market, by Equipment – Revenue and Forecast to 2030 (US$ Million)
Table 21. Rest of Middle East & Africa Bioproduction Market, For Bioreactors by Equipment- Revenue and Forecast to 2030 (US$ Million)
Table 22. Rest of Middle East & Africa Bioproduction Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 23. Recent Inorganic Growth Strategies in the Bioproduction Market
Table 24. Recent Organic Growth Strategies in the Bioproduction Market
Table 25. Glossary of Terms, Bioproduction Market

LIST OF FIGURES

Figure 1. Middle East & Africa Bioproduction Market Segmentation, By Country
Figure 2. Middle East & Africa Bioproduction Market: Key Industry Dynamics
Figure 3. Middle East & Africa Bioproduction Market: Impact Analysis of Drivers and Restraints
Figure 4. Middle East & Africa Bioproduction Market Revenue (US$ Mn), 2020 – 2030
Figure 5. Middle East & Africa Bioproduction Market Revenue Share, by Product 2022 & 2030 (%)
Figure 6. Biologics and Biosimilars: Middle East & Africa Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
Figure 7. Vaccines: Middle East & Africa Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
Figure 8. Cell and Gene Therapies: Middle East & Africa Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
Figure 9. Nucleic Acid Therapeutics: Middle East & Africa Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
Figure 10. Others: Middle East & Africa Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
Figure 11. Middle East & Africa Bioproduction Market Revenue Share, by Application 2022 & 2030 (%)
Figure 12. Cancer: Middle East & Africa Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
Figure 13. Cardiovascular Diseases: Middle East & Africa Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
Figure 14. Rheumatoid Arthritis: Middle East & Africa Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
Figure 15. Hematological Disorders: Middle East & Africa Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
Figure 16. Diabetes: Middle East & Africa Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
Figure 17. Others: Middle East & Africa Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
Figure 18. Middle East & Africa Bioproduction Market Revenue Share, by Equipment 2022 & 2030 (%)
Figure 19. Consumables and Accessories: Middle East & Africa Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
Figure 20. Downstream Equipment: Middle East & Africa Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
Figure 21. Bioreactors: Middle East & Africa Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
Figure 22. Upstream Equipment: Middle East & Africa Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
Figure 23. Middle East & Africa Bioproduction Market Revenue Share, by End User 2022 & 2030 (%)
Figure 24. Biopharmaceutical Companies: Middle East & Africa Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
Figure 25. Contract Manufacturing Organizations: Middle East & Africa Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
Figure 26. Others: Middle East & Africa Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
Figure 27. Middle East & Africa: Bioproduction Market, by Key Country – Revenue (2022) (US$ Million)
Figure 28. Middle East & Africa: Bioproduction Market, by Country, 2022 & 2030 (%)
Figure 29. Saudi Arabia: Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
Figure 30. South Africa: Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
Figure 31. UAE: Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
Figure 32. Rest of Middle East & Africa: Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
Figure 33. Growth Strategies in the Bioproduction Market

1. Lonza Group AG
2. Danaher Corp
3. Sartorius AG
4. Thermo Fisher Scientific Inc
5. Merck KGaA
6. F. Hoffmann-La Roche Ltd
7. Bio-Rad Laboratories Inc

Reviews

There are no reviews yet.

Be the first to review “Middle East & Africa Bioproduction Market Forecast to 2030”